![Andrew Jane](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Jane
Founder at
Talu Ventures Pty Ltd.
Profile
Andy is one of the three founders of Talu Ventures which was established as the successor to CM Capital.
Andy joined CM Capital in August 2003 and assumed the role of head of the Life Sciences Practice at CM in 2006.
Prior to his venture investment roles, Andy has 15 years of experience in biomedical R&D project management, marketing and business development.
His primary expertise is in the commercialisation and globalisation of technology based products and brings to Talu an extensive network of industry contacts within the biotechnology, high technology and pharmaceutical industries.
Andy has active Board roles across the CMVT4 Life Sciences portfolio and adds to those companies the benefit of his international experience in business development, contractual negotiation, strategic relationship building and licensing.
Within Andy’s professional career he spent 5 years at AGEN, where he was responsible for the management of the company’s instrumentation and biosensor program and latterly for the primary business planning and management of the Thromboview Project.
More recently he spent 4 years at Lake Technology as Director of Business Development & Licensing, where he was instrumental in the worldwide business development and marketing of Dolby Headphone™ and Dolby Virtual Speaker™ technologies which have since been adopted by leading brand consumer electronics companies, airlines and PC companies.
Andrew Jane active positions
| Companies | Position | Start |
|---|---|---|
Advent Pharmaceuticals Pty Ltd.
 Advent Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology Designs and develops dry powder inhaler devices | Director/Board Member | - |
Piedmont Pharmaceuticals Pty Ltd. | Director/Board Member | - |
Talu Ventures Pty Ltd.
 Talu Ventures Pty Ltd. Investment ManagersFinance Talu Ventures invests in technology companies located in Australia. The firm targets companies operating in the fields of life sciences, biotechnology, medical devices, pharmaceuticals and renewable energy. It provides financing for early and expansion capital requirements with an investment size of AUD 5 to AUD 15 million. They also take a seat on board of directors. | Founder | 2012-12-31 |
SpeeDx, Inc.
 SpeeDx, Inc. Miscellaneous Commercial ServicesCommercial Services SpeeDx, Inc. is a company based in Austin, TX. The company was founded in 2016. | Director/Board Member | - |
Ocaro Pharmaceuticals, Inc.
 Ocaro Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research & development and production of opioid-sparing pain medications | Director/Board Member | 2007-10-31 |
Former positions of Andrew Jane
| Companies | Position | End |
|---|---|---|
Piedmont Pharmaceuticals, Inc.
 Piedmont Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures veterinary pharmaceuticals | Director/Board Member | 2022-06-30 |
SpeeDx Pty Ltd.
 SpeeDx Pty Ltd. BiotechnologyHealth Technology Develops molecular diagnostic detection technologies | Director/Board Member | 2021-03-31 |
| OSPY MEDI CDI | Director/Board Member | 2020-08-17 |
Altiris Therapeutics, Inc.
 Altiris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs for treat metastatic cancer | Director/Board Member | 2016-06-30 |
| ░░░░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of Andrew Jane
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
40
1st degree connections
16
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 16 |
|---|---|
Piedmont Pharmaceuticals, Inc.
Piedmont Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures veterinary pharmaceuticals | Health Technology |
Universal Biosensors, Inc.
 Universal Biosensors, Inc. Medical SpecialtiesHealth Technology Manufactures vitro diagnostic test devices | Health Technology |
Altiris Therapeutics, Inc.
Altiris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs for treat metastatic cancer | Health Technology |
Lake Technology Ltd.
 Lake Technology Ltd. Miscellaneous Commercial ServicesCommercial Services Commercializes and licenses technologies that use digital signal processing | Commercial Services |
Dolby Laboratories, Inc.
 Dolby Laboratories, Inc. Packaged SoftwareTechnology Services Develops audio and imaging technologies and products for cinema, television, broadcast & entertainment industries | Technology Services |
CM Capital Investments Pty Ltd.
 CM Capital Investments Pty Ltd. Investment ManagersFinance CM Capital is a hands-on manager which invests in early-stage Australian life sciences (specialty pharmaceuticals, medical devices, drug discovery), telecommunications/IT (mobile telecommunications infrastructure, mobile commerce, data communications, mobile social networking, internet advertising, internet security) and renewable energy companies which can establish market leadership positions in their respective market sectors. The firm seeks to invest AUD 0.5-5 million in companies with talented management, differentiated products with high barriers to entry, products/technology or business models with sustainable competitive advantages, intellectual property owned by the company or in exclusive worldwide use, substantial market opportunities, a clearly defined growth strategy, completed proof of concept and a clear analysis of their market and competitors. CM Capital partners with their investee companies, taking a board seat and providing support including identifying and assisting with recruitment of key employees, board members and strategic advisors, providing introductions to potential customers and strategic partners, working with entrepreneurs to develop their management talents, providing introductions to leading venture capital funds and investment banks, assisting in the development of relationships and strategies to enter global markets and assisting in IPO or M&A transactions. | Finance |
University of St. Andrews
 University of St. Andrews Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Manchester Institute of Science & Technology
 University of Manchester Institute of Science & Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Universal Biosensors Pty Ltd.
 Universal Biosensors Pty Ltd. Medical SpecialtiesHealth Technology Manufactures diagnostic test systems | Health Technology |
Advent Pharmaceuticals Pty Ltd.
Advent Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology Designs and develops dry powder inhaler devices | Health Technology |
Osprey Medical, Inc.
 Osprey Medical, Inc. Medical SpecialtiesHealth Technology Develops medicine for cardiovascular diseases | Health Technology |
SpeeDx Pty Ltd.
SpeeDx Pty Ltd. BiotechnologyHealth Technology Develops molecular diagnostic detection technologies | Health Technology |
Piedmont Pharmaceuticals Pty Ltd. | |
Talu Ventures Pty Ltd.
Talu Ventures Pty Ltd. Investment ManagersFinance Talu Ventures invests in technology companies located in Australia. The firm targets companies operating in the fields of life sciences, biotechnology, medical devices, pharmaceuticals and renewable energy. It provides financing for early and expansion capital requirements with an investment size of AUD 5 to AUD 15 million. They also take a seat on board of directors. | Finance |
SpeeDx, Inc.
SpeeDx, Inc. Miscellaneous Commercial ServicesCommercial Services SpeeDx, Inc. is a company based in Austin, TX. The company was founded in 2016. | Commercial Services |
Ocaro Pharmaceuticals, Inc.
Ocaro Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research & development and production of opioid-sparing pain medications | Commercial Services |
- Stock Market
- Insiders
- Andrew Jane
